Cargando…
Preoperative recombinant human erythropoietin in anemic surgical patients
Preoperative anemia in a surgical patient predisposes to poor outcomes and allogeneic blood transfusions. As an alternative to transfusions, pharmacologic management of preoperative anemia with recombinant human erythropoietin (rHuEPO) has been well studied in many different types of surgery. rHuEPO...
Autor principal: | Monk, Terri G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226151/ https://www.ncbi.nlm.nih.gov/pubmed/15196324 http://dx.doi.org/10.1186/cc2824 |
Ejemplares similares
-
Predictors of iron versus erythropoietin responsiveness in anemic hemodialysis patients
por: Hildebrand, Sarah, et al.
Publicado: (2022) -
The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions
por: Palazzuoli, Alberto, et al.
Publicado: (2014) -
Role of preoperative erythropoietin in the optimization of preoperative anemia among surgical patients — A systematic review and meta-analysis
por: Ali, Sheikh Muhammad Ebad, et al.
Publicado: (2022) -
Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005) -
The Clinical Impact of Recombinant Human Erythropoietin
por: Muirhead, N
Publicado: (1997)